Glucagon vs Insulin Aspart
Head-to-head comparison of Glucagon (Glucagon) and Insulin Aspart (Insulin aspart (B28-Asp human insulin analog)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Glucagon | Insulin Aspart |
|---|---|---|
| Category | Diabetes & Metabolic | Diabetes & Metabolic |
| Full Name | Glucagon | Insulin aspart (B28-Asp human insulin analog) |
| Molecular Weight | 3482.75 | 5825.8 Da |
| Half-Life | 5-10 min | About 1-3 hours |
| Amino Acids | 29 | 51 |
| Typical Dose | 1 mg IM/SC for severe hypoglycemia or 3 mg intranasal | 0.05-0.2 U/kg per meal |
| Route | IM|SC|IN|IV | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 93 | 11000 |
| Research Status | Approved | Approved |
Glucagon Benefits
- ✓rapid hypoglycemia reversal
- ✓raises plasma glucose
- ✓useful in emergency rescue
Insulin Aspart Benefits
- ✓Fast post-meal glucose lowering
- ✓Predictable onset
- ✓Flexible mealtime administration
- ✓Compatible with pump therapy
Glucagon Dosing
1 mg IM/SC|3 mg intranasal
Insulin Aspart Dosing
Inject SC immediately before meals|Titrate using glucose monitoring and carbohydrate intake|Can be used in insulin pumps or basal-bolus regimens
Glucagon Side Effects
- ⚠nausea
- ⚠vomiting
Insulin Aspart Side Effects
- ⚠Hypoglycemia
- ⚠Injection-site reactions
- ⚠Weight gain
Research Overview
Glucagon
Clinical and emergency medicine use is well established for severe hypoglycemia, with newer stable formulations improving ease of administration.
Insulin Aspart
Research consistently shows faster onset and earlier peak action than regular human insulin. It is commonly studied for meal-time glycemic control and pump-based insulin delivery.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.